AIQ Solutions Announces a New Category III CPT Code for Determining Heterogeneity of Change Across All Lesions prn.to/40HAxA6
Timothy Perk retweeted
Eligibility for PSMA-RLT based on dual FDG/PSMA-PET: a subanalysis of the #3TMPO study. Presentation by Jean-Mathieu Beauregard @chudequebec. #SNMMI24 written coverage by @zklaassen_md @GACancerCenter > bit.ly/4aTpkzj @SNM_MI
Timothy Perk retweeted
Congratulations to the @wiscmedphys @UWSMPH researchers awarded patents in March: Daniel Huff & Robert Jeraj!
Tell us your idea: warf.org/disclose
See the patent: ppubs.uspto.gov/dirsearch-pu…
Timothy Perk retweeted
Dr. Robert Jeraj, AIQ CSO and faculty member of the @UWMadison , will be a featured speaker on Course 5 of @sitcancer and @thenci Computational Immuno-oncology Webinar Series, moderated by Dr. Matthew Reilley. Register today! sitc.execinc.com/edibo/NCI23…
#immunotherapy #immunooncology #webinar
Timothy Perk retweeted
1/ Excited to share our latest paper! 🧵
Performance of an automated registration-based method for longitudinal lesion matching and comparison to inter-reader variability doi.org/10.1088/1361-6560/ac… via @ioppublishing
Timothy Perk retweeted
To learn more about our Early Access Program visit traqinformiq.com.
Timothy Perk retweeted
We are getting excited to be at #SNMMI2023 next weekend in Chicago. Please reach out today to schedule a time to meet with us at Booth 8053. aiq-solutions.com
Timothy Perk retweeted
We have a fantastic team of rising ⭐️s @EliasChandran @GMIannantuonoMD @NicholasISimon @NCIResearchCtr presenting our #BladderCancer posters on 1]mismatch repair deficiency & MSI 2]Olaparib biomarker-selected TPS 3]M7824 +NHS-IL12 +/-XRT study 4] AI with PET/CT @ASCO #ASCO23
It is great to be between two young rising stars in GU oncology working at @nciccr_gmb 🔥🔝
@EliasChandran @NicholasISimon
#ASCO2023
Timothy Perk retweeted
We are at #ASCO23 and we have a booth and a kiosk - two times the reasons to stop by and say hi! Visit our #booth 18045 to learn more about our Hospital Early Access Program or come by our #kiosk IH23 in the Innovation Hub to learn more about our clinical research applications for therapy and tracer development. We look forward to seeing you! Click here to learn more aiq-solutions.com.
Timothy Perk retweeted
We are at @ASCO #GU23 today and tomorrow! Meet us at Poster Session B: Prostate Cancer and Urothelial Carcinoma, Friday, Feb 17, 12:30pm PT or stop by Booth 39 to learn more about TRAQinform IQ technology. #ai #technology
Timothy Perk retweeted
Learn about the future of oncology and therapy: ow.ly/5BcK50Mogfc
#MolecularImaging and #Theranostics = Precision Oncology
#Cancer #NuclearMedicine #JNuclMed
Timothy Perk retweeted
Imaging adaptive immune responses to immunotherapies to improve outcomes. ow.ly/Lfjy50LZtxC
#MolecularImaging = #PrecisionOncology
#NuclearMedicine #Cancer @UABRadiology
Timothy Perk retweeted
This week Thursday! Join our Imaging Innovations #webinar with distinguished professor and #amyloidosis expert Dr. Jonathan Wall of @utgsm and our own @aj_weisman to hear the latest on #AI imaging. Register for free: buff.ly/3EGfioz
So incredibly proud of Andrew Sedlack @ajhsedlack presenting our work on Application of Novel Machine Learning Model in Predicting Survival in Adrenocortical Cancer. The future is bright!! @myESMO @NUMSTP @netcancerday @LetsCureAcc @accCURE @NUFeinbergMed @NIBIBgov @NIH_OITE
Timothy Perk retweeted
And he just received a Best Poster Award!! Congratulations Andrew Sedlack @ajhsedlack!!





































